{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:17:36Z","timestamp":1774790256296,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1186\/s12920-018-0327-0","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T15:18:15Z","timestamp":1518535095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exome analysis of carotid body tumor"],"prefix":"10.1186","volume":"11","author":[{"given":"Anastasiya V.","family":"Snezhkina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Lukyanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry V.","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly V.","family":"Pokrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda V.","family":"Koroban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Pudova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda N.","family":"Volchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg A.","family":"Stepanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina A.","family":"Zhevelyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey L.","family":"Kharitonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiya V.","family":"Lipatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan S.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Golovyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yegor E.","family":"Yegorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khava S.","family":"Vishnyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Moskalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya V.","family":"Melnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry S.","family":"Shcherbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V.","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey D.","family":"Kaprin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris Y.","family":"Alekseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Zaretsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Kudryavtseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"issue":"2","key":"327_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.amjsurg.2013.06.002","volume":"207","author":"B Amato","year":"2014","unstructured":"Amato B, Bianco T, Compagna R, Siano M, Esposito G, Buffone G, Serra R, de Franciscis S. Surgical resection of carotid body paragangliomas: 10 years of experience. Am J Surg. 2014;207(2):293\u20138.","journal-title":"Am J Surg"},{"issue":"15","key":"327_CR2","doi-asserted-by":"publisher","first-page":"25756","DOI":"10.18632\/oncotarget.15201","volume":"8","author":"SO Zhikrivetskaya","year":"2017","unstructured":"Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, Alekseev BY, Pokrovsky AV, Golovyuk AL, Melnikova NV, Stepanov OA, Kalinin DV, Moskalev AA, et al. Molecular markers of paragangliomas\/pheochromocytomas. Oncotarget. 2017;8(15):25756\u201382.","journal-title":"Oncotarget"},{"issue":"5","key":"327_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0031-1301302","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","unstructured":"Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44(5):328\u201333.","journal-title":"Horm Metab Res"},{"issue":"19","key":"327_CR4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459\u201366.","journal-title":"N Engl J Med"},{"issue":"5454","key":"327_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848\u201351.","journal-title":"Science"},{"issue":"26","key":"327_CR6","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1093\/hmg\/dds374","volume":"21","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Buffet A, Parfait B, Letouze E, Laurendeau I, Loriot C, Pasmant E, Abermil N, Valeyrie-Allanore L, Bertherat J, et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Hum Mol Genet. 2012;21(26):5397\u2013405.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"327_CR7","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Cascon A, Schiavi F, Morales NP, Comino-Mendez I, Abermil N, Inglada-Perez L, de Cubas AA, Amar L, Barontini M, et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res. 2012;18(10):2828\u201337.","journal-title":"Clin Cancer Res"},{"issue":"26","key":"327_CR8","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1093\/hmg\/dds402","volume":"21","author":"J Welander","year":"2012","unstructured":"Welander J, Larsson C, Backdahl M, Hareni N, Sivler T, Brauckhoff M, Soderkvist P, Gimm O. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet. 2012;21(26):5406\u201316.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"327_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1530\/ERC-13-0101","volume":"20","author":"RA Toledo","year":"2013","unstructured":"Toledo RA, Qin Y, Srikantan S, Morales NP, Li Q, Deng Y, Kim SW, Pereira MA, Toledo SP, Su X, et al. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2013;20(3):349\u201359.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"327_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, et al. Comprehensive molecular characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017;31(2):181\u201393.","journal-title":"Cancer Cell"},{"issue":"1","key":"327_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","volume":"161","author":"B Babic","year":"2017","unstructured":"Babic B, Patel D, Aufforth R, Assadipour Y, Sadowski SM, Quezado M, Nilubol N, Prodanov T, Pacak K, Kebebew E. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Surgery. 2017;161(1):220\u20137.","journal-title":"Surgery"},{"issue":"7239","key":"327_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719\u201324.","journal-title":"Nature"},{"issue":"8","key":"327_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/gm175","volume":"2","author":"GP Pfeifer","year":"2010","unstructured":"Pfeifer GP. Environmental exposures and mutational patterns of cancer genomes. Genome Med. 2010;2(8):54.","journal-title":"Genome Med"},{"issue":"5","key":"327_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molcel.2012.07.006","volume":"47","author":"J Pena-Diaz","year":"2012","unstructured":"Pena-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Boran M, Castor D, Lopes M, Sartori AA, Jiricny J. Noncanonical mismatch repair as a source of genomic instability in human cells. Mol Cell. 2012;47(5):669\u201380.","journal-title":"Mol Cell"},{"issue":"7463","key":"327_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature"},{"issue":"3","key":"327_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-017-2390-3","volume":"132","author":"M Sinnadurai","year":"2017","unstructured":"Sinnadurai M, McDonald KL. Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma. J Neuro-Oncol. 2017;132(3):359\u201372.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"327_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1547691X.2013.798388","volume":"11","author":"RA Ponce","year":"2014","unstructured":"Ponce RA, Gelzleichter T, Haggerty HG, Heidel S, Holdren MS, Lebrec H, Mellon RD, Pallardy M. Immunomodulation and lymphoma in humans. J Immunotoxicol. 2014;11(1):1\u201312.","journal-title":"J Immunotoxicol"},{"key":"327_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-015-0104-y","volume":"3","author":"MP Castro","year":"2015","unstructured":"Castro MP, Goldstein N. Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations. J Immunother Cancer. 2015;3:58.","journal-title":"J Immunother Cancer"},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2016.06.008","volume":"48","author":"P Gargiulo","year":"2016","unstructured":"Gargiulo P, Della Pepa C, Berardi S, Califano D, Scala S, Buonaguro L, Ciliberto G, Brauchli P, Pignata S. Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy? Cancer Treat Rev. 2016;48:61\u20138.","journal-title":"Cancer Treat Rev"},{"issue":"1\u20132","key":"327_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0005-2728(01)00228-6","volume":"1553","author":"P Rustin","year":"2002","unstructured":"Rustin P, Rotig A. Inborn errors of complex II--unusual human mitochondrial diseases. Biochim Biophys Acta. 2002;1553(1\u20132):117\u201322.","journal-title":"Biochim Biophys Acta"},{"issue":"5607","key":"327_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.1079605","volume":"299","author":"V Yankovskaya","year":"2003","unstructured":"Yankovskaya V, Horsefield R, Tornroth S, Luna-Chavez C, Miyoshi H, Leger C, Byrne B, Cecchini G, Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003;299(5607):700\u20134.","journal-title":"Science"},{"issue":"6","key":"327_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ng.378","volume":"41","author":"D Ghezzi","year":"2009","unstructured":"Ghezzi D, Goffrini P, Uziel G, Horvath R, Klopstock T, Lochmuller H, D'Adamo P, Gasparini P, Strom TM, Prokisch H, et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet. 2009;41(6):654\u20136.","journal-title":"Nat Genet"},{"issue":"5944","key":"327_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009;325(5944):1139\u201342.","journal-title":"Science"},{"issue":"4","key":"327_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","volume":"24","author":"E Castelblanco","year":"2013","unstructured":"Castelblanco E, Santacana M, Valls J, de Cubas A, Cascon A, Robledo M, Matias-Guiu X. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas. Endocr Pathol. 2013;24(4):199\u2013205.","journal-title":"Endocr Pathol"},{"issue":"3","key":"327_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW, Pacak K. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92(3):779\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR26","first-page":"502734","volume":"2014","author":"H Choat","year":"2014","unstructured":"Choat H, Derrevere K, Knight L, Brown W, Mack EH. SDHB-associated Paraganglioma in a pediatric patient and literature review on hereditary Pheochromocytoma-Paraganglioma syndromes. Case Rep Endocrinol. 2014;2014:502734.","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"327_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.24572","volume":"79","author":"G Helman","year":"2016","unstructured":"Helman G, Caldovic L, Whitehead MT, Simons C, Brockmann K, Edvardson S, Bai R, Moroni I, Taylor JM, Van Haren K, et al. Magnetic resonance imaging spectrum of succinate dehydrogenase-related infantile leukoencephalopathy. Ann Neurol. 2016;79(3):379\u201386.","journal-title":"Ann Neurol"},{"issue":"6","key":"327_CR28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","volume":"188","author":"CJ Ricketts","year":"2012","unstructured":"Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012;188(6):2063\u201371.","journal-title":"J Urol"},{"issue":"3","key":"327_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/jmedgenet-2013-101932","volume":"51","author":"CB Jackson","year":"2014","unstructured":"Jackson CB, Nuoffer JM, Hahn D, Prokisch H, Haberberger B, Gautschi M, Haberli A, Gallati S, Schaller A. Mutations in SDHD lead to autosomal recessive encephalomyopathy and isolated mitochondrial complex II deficiency. J Med Genet. 2014;51(3):170\u20135.","journal-title":"J Med Genet"},{"key":"327_CR30","doi-asserted-by":"crossref","unstructured":"Gaal J,\u00a0Burnichon N,\u00a0Korpershoek E,\u00a0Roncelin I,\u00a0Bertherat J,\u00a0Plouin PF,\u00a0de Krijger RR,\u00a0Gimenez-Roqueplo AP,\u00a0Dinjens WN. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and\u00a0paragangliomas. J Clin Endocrinol Metab.\u00a02010;95(3):1274-8.","DOI":"10.1210\/jc.2009-2170"},{"issue":"3","key":"327_CR31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1210\/jc.2009-2170","volume":"95","author":"J Gaal","year":"2010","unstructured":"Gaal J, Burnichon N, Korpershoek E, Roncelin I, Bertherat J, Plouin PF, de Krijger RR, Gimenez-Roqueplo AP, Dinjens WN. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2010;95(3):1274\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"327_CR32","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1001\/jama.2010.1830","volume":"304","author":"L Yao","year":"2010","unstructured":"Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Perez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, et al. Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA. 2010;304(23):2611\u20139.","journal-title":"JAMA"},{"issue":"13","key":"327_CR33","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.18632\/oncotarget.3448","volume":"6","author":"CR Huang","year":"2015","unstructured":"Huang CR, Lee CT, Chang KY, Chang WC, Liu YW, Lee JC, Chen BK. Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin\/integrin beta1\/FAK axis. Oncotarget. 2015;6(13):11530\u201346.","journal-title":"Oncotarget"},{"issue":"13","key":"327_CR34","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1073\/pnas.91.13.6098","volume":"91","author":"K Iwabuchi","year":"1994","unstructured":"Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S. Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci U S A. 1994;91(13):6098\u2013102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"327_CR35","doi-asserted-by":"publisher","first-page":"26061","DOI":"10.1074\/jbc.273.40.26061","volume":"273","author":"K Iwabuchi","year":"1998","unstructured":"Iwabuchi K, Li B, Massa HF, Trask BJ, Date T, Fields S. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J Biol Chem. 1998;273(40):26061\u20138.","journal-title":"J Biol Chem"},{"issue":"5","key":"327_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1507\/endocrj.EJ15-0629","volume":"63","author":"Z Mussazhanova","year":"2016","unstructured":"Mussazhanova Z, Akazawa Y, Matsuda K, Shichijo K, Miura S, Otsubo R, Oikawa M, Yoshiura K, Mitsutake N, Rogounovitch T, et al. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid. Endocr J. 2016;63(5):457\u201367.","journal-title":"Endocr J"},{"issue":"6","key":"327_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nsmb.1831","volume":"17","author":"P Bouwman","year":"2010","unstructured":"Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol. 2010;17(6):688\u201395.","journal-title":"Nat Struct Mol Biol"},{"issue":"5289","key":"327_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.274.5289.1001","volume":"274","author":"S Gorina","year":"1996","unstructured":"Gorina S, Pavletich NP. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science. 1996;274(5289):1001\u20135.","journal-title":"Science"},{"issue":"23","key":"327_CR39","doi-asserted-by":"publisher","first-page":"14611","DOI":"10.1074\/jbc.272.23.14611","volume":"272","author":"G Pirozzi","year":"1997","unstructured":"Pirozzi G, McConnell SJ, Uveges AJ, Carter JM, Sparks AB, Kay BK, Fowlkes DM. Identification of novel human WW domain-containing proteins by cloning of ligand targets. J Biol Chem. 1997;272(23):14611\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"327_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000134630","volume":"78","author":"JP Yang","year":"1997","unstructured":"Yang JP, Ono T, Sonta S, Kawabe T, Okamoto T. Assignment of p53 binding protein (TP53BP2) to human chromosome band 1q42.1 by in situ hybridization. Cytogenet Cell Genet. 1997;78(1):61\u20132.","journal-title":"Cytogenet Cell Genet"},{"issue":"37","key":"327_CR41","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1038\/sj.onc.1202904","volume":"18","author":"JP Yang","year":"1999","unstructured":"Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene. 1999;18(37):5177\u201386.","journal-title":"Oncogene"},{"issue":"24 Pt 1","key":"327_CR42","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1158\/1078-0432.CCR-05-0735","volume":"11","author":"MA Cobleigh","year":"2005","unstructured":"Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu ML, Borchik R, Mosquera JM, Walker MG, Shak S. Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res. 2005;11(24 Pt 1):8623\u201331.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"327_CR43","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ijc.21281","volume":"117","author":"H Ju","year":"2005","unstructured":"Ju H, Lee KA, Yang M, Kim HJ, Kang CP, Sohn TS, Rhee JC, Kang C, Kim JW. TP53BP2 locus is associated with gastric cancer susceptibility. Int J Cancer. 2005;117(6):957\u201360.","journal-title":"Int J Cancer"},{"issue":"12","key":"327_CR44","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1080\/1042819021000040017","volume":"43","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Natkunam Y, Levy R, Lopez CD. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome. Leuk Lymphoma. 2002;43(12):2309\u201317.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"327_CR45","first-page":"513","volume":"24","author":"T Hata","year":"2004","unstructured":"Hata T, Ogawa T, Yokoyama TA, Fukushige S, Horii A, Furukawa T. DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro. Int J Oncol. 2004;24(3):513\u201320.","journal-title":"Int J Oncol"},{"issue":"2","key":"327_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0304-3835(03)00456-7","volume":"204","author":"M Ichihara","year":"2004","unstructured":"Ichihara M, Murakumo Y, Takahashi M. RET and neuroendocrine tumors. Cancer Lett. 2004;204(2):197\u2013211.","journal-title":"Cancer Lett"},{"issue":"5516","key":"327_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5516):468\u201372.","journal-title":"Science"},{"issue":"5","key":"327_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mgg3.86","volume":"2","author":"Y Freudenberg-Hua","year":"2014","unstructured":"Freudenberg-Hua Y, Freudenberg J, Vacic V, Abhyankar A, Emde AK, Ben-Avraham D, Barzilai N, Oschwald D, Christen E, Koppel J, et al. Disease variants in genomes of 44 centenarians. Mol Genet Genomic Med. 2014;2(5):438\u201350.","journal-title":"Mol Genet Genomic Med"},{"issue":"11","key":"327_CR49","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1210\/jc.2005-1278","volume":"90","author":"SM Baumgartner-Parzer","year":"2005","unstructured":"Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhausl W, Vierhapper H. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab. 2005;90(11):6232\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"327_CR50","doi-asserted-by":"publisher","first-page":"E2084","DOI":"10.1210\/jc.2014-1734","volume":"99","author":"G Figlioli","year":"2014","unstructured":"Figlioli G, Kohler A, Chen B, Elisei R, Romei C, Cipollini M, Cristaudo A, Bambi F, Paolicchi E, Hoffmann P, et al. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. J Clin Endocrinol Metab. 2014;99(10):E2084\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"327_CR51","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/0092-8674(94)90012-4","volume":"79","author":"M Nangaku","year":"1994","unstructured":"Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H, Hirokawa N. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell. 1994;79(7):1209\u201320.","journal-title":"Cell"},{"issue":"5","key":"327_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(01)00363-4","volume":"105","author":"C Zhao","year":"2001","unstructured":"Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, et al. Charcot-Marie-tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 2001;105(5):587\u201397.","journal-title":"Cell"},{"issue":"7","key":"327_CR53","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1101\/gad.1648608","volume":"22","author":"S Schlisio","year":"2008","unstructured":"Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 2008;22(7):884\u201393.","journal-title":"Genes Dev"},{"issue":"3","key":"327_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00439-008-0553-1","volume":"124","author":"IT Yeh","year":"2008","unstructured":"Yeh IT, Lenci RE, Qin Y, Buddavarapu K, Ligon AH, Leteurtre E, Do Cao C, Cardot-Bauters C, Pigny P, Dahia PL. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum Genet. 2008;124(3):279\u201385.","journal-title":"Hum Genet"},{"issue":"7","key":"327_CR55","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","volume":"99","author":"J Welander","year":"2014","unstructured":"Welander J, Andreasson A, Juhlin CC, Wiseman RW, Backdahl M, Hoog A, Larsson C, Gimm O, Soderkvist P. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2014;99(7):E1352\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"327_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1158\/0008-5472.CAN-05-2720","volume":"66","author":"KP Hoeflich","year":"2006","unstructured":"Hoeflich KP, Gray DC, Eby MT, Tien JY, Wong L, Bower J, Gogineni A, Zha J, Cole MJ, Stern HM, et al. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res. 2006;66(2):999\u20131006.","journal-title":"Cancer Res"},{"key":"327_CR57","doi-asserted-by":"publisher","first-page":"138573","DOI":"10.1155\/2015\/138573","volume":"2015","author":"A Luchetti","year":"2015","unstructured":"Luchetti A, Walsh D, Rodger F, Clark G, Martin T, Irving R, Sanna M, Yao M, Robledo M, Neumann HP, et al. Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis. Int J Endocrinol. 2015;2015:138573.","journal-title":"Int J Endocrinol"},{"issue":"6627","key":"327_CR58","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/386761a0","volume":"386","author":"KW Kinzler","year":"1997","unstructured":"Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 1997;386(6627):761. 763","journal-title":"Nature"},{"key":"327_CR59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4137\/BCBCR.S18715","volume":"8","author":"MJ Larsen","year":"2014","unstructured":"Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl). 2014;8:145\u201355.","journal-title":"Breast Cancer (Auckl)"},{"issue":"2","key":"327_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/cncr.29041","volume":"121","author":"J Mersch","year":"2015","unstructured":"Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121(2):269\u201375.","journal-title":"Cancer"},{"issue":"3","key":"327_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/1096-8628(20010122)98:3<277::AID-AJMG1082>3.0.CO;2-Q","volume":"98","author":"F Barak","year":"2001","unstructured":"Barak F, Shiri-Svredlov R, Bruchim-Bar Sade R, Kruglikova A, Friedman E, Ben-Dor D, Goldberg I. Adrenal tumors in BRCA1\/BRCA2 mutation carriers. Am J Med Genet. 2001;98(3):277\u20139.","journal-title":"Am J Med Genet"},{"issue":"3","key":"327_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"327_CR63","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","volume":"45","author":"R Murali","year":"2013","unstructured":"Murali R, Wiesner T, Scolyer RA. Tumours associated with BAP1 mutations. Pathology. 2013;45(2):116\u201326.","journal-title":"Pathology"},{"issue":"6","key":"327_CR64","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/pcmr.12006","volume":"25","author":"K Wadt","year":"2012","unstructured":"Wadt K, Choi J, Chung JY, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, et al. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res. 2012;25(6):815\u20138.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6159","key":"327_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/332085a0","volume":"332","author":"C Larsson","year":"1988","unstructured":"Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988;332(6159):85\u20137.","journal-title":"Nature"},{"issue":"7","key":"327_CR66","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/hmg\/6.7.1169","volume":"6","author":"SK Agarwal","year":"1997","unstructured":"Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6(7):1169\u201375.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"327_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ejhg.2013.128","volume":"22","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Favier J, Pertuit M, Delage-Corre M, Lopez S, Teissier MP, Mathonnet M, Galinat S, Barlier A, Archambeaud F. A MEN1 syndrome with a paraganglioma. Eur J Hum Genet. 2014;22(2):283\u20135.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"327_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1043-2760(00)00372-6","volume":"12","author":"DH Schussheim","year":"2001","unstructured":"Schussheim DH, Skarulis MC, Agarwal SK, Simonds WF, Burns AL, Spiegel AM, Marx SJ. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab. 2001;12(4):173\u20138.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"327_CR69","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, Soderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18(6):R253\u201376.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"327_CR70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","volume":"24","author":"RV Thakker","year":"2010","unstructured":"Thakker RV. Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab. 2010;24(3):355\u201370.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"327_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajhg.2012.05.021","volume":"91","author":"JJ Johnston","year":"2012","unstructured":"Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet. 2012;91(1):97\u2013108.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"327_CR72","first-page":"441","volume":"85","author":"KM Schulte","year":"2000","unstructured":"Schulte KM, Mengel M, Heinze M, Simon D, Scheuring S, Kohrer K, Roher HD. Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer. J Clin Endocrinol Metab. 2000;85(1):441\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-014-0167-x","volume":"2","author":"GM Shankar","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014;2:167.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"327_CR74","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1067\/msy.2099.101376","volume":"126","author":"AP Dackiw","year":"1999","unstructured":"Dackiw AP, Cote GJ, Fleming JB, Schultz PN, Stanford P, Vassilopoulou-Sellin R, Evans DB, Gagel RF, Lee JE. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery. 1999;126(6):1097\u2013103. discussion 1103-1094","journal-title":"Surgery"},{"issue":"4","key":"327_CR75","doi-asserted-by":"publisher","first-page":"e94554","DOI":"10.1371\/journal.pone.0094554","volume":"9","author":"DL Bodian","year":"2014","unstructured":"Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing. PLoS One. 2014;9(4):e94554.","journal-title":"PLoS One"},{"issue":"3","key":"327_CR76","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1590\/1516-3180.2014.1323452","volume":"132","author":"AL Casarim","year":"2014","unstructured":"Casarim AL, Tincani AJ, Del Negro A, Aguiar CG, Fanni RV, Martins AS. Carotid body tumor: retrospective analysis on 22 patients. Sao Paulo Med J. 2014;132(3):133\u20139.","journal-title":"Sao Paulo Med J"},{"issue":"Suppl 1","key":"327_CR77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6061\/clinics\/2012(Sup01)05","volume":"67","author":"C Offergeld","year":"2012","unstructured":"Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke HC, Glasker S, Schmid KW, Wiech T, Preuss SF, Suarez C, et al. Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo). 2012;67(Suppl 1):19\u201328.","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"327_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, et al. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat. 2010;31(1):41\u201351.","journal-title":"Hum Mutat"},{"issue":"11","key":"327_CR79","first-page":"43","volume":"31","author":"J Reichman","year":"1989","unstructured":"Reichman J, Healey WC. Amplification monitoring and maintenance in schools. ASHA. 1989;31(11):43\u20135.","journal-title":"ASHA"},{"issue":"6","key":"327_CR80","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0002-9610(71)90436-3","volume":"122","author":"WR Shamblin","year":"1971","unstructured":"Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732\u20139.","journal-title":"Am J Surg"},{"issue":"12","key":"327_CR81","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1210\/me.2010-0256","volume":"24","author":"E Lopez-Jimenez","year":"2010","unstructured":"Lopez-Jimenez E, Gomez-Lopez G, Leandro-Garcia LJ, Munoz I, Schiavi F, Montero-Conde C, de Cubas AA, Ramires R, Landa I, Leskela S, et al. Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrinol. 2010;24(12):2382\u201391.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"327_CR82","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1101\/gr.183053.114","volume":"25","author":"S Hiltemann","year":"2015","unstructured":"Hiltemann S, Jenster G, Trapman J, van der Spek P, Stubbs A. Discriminating somatic and germline mutations in tumor DNA samples without matching normals. Genome Res. 2015;25(9):1382\u201390.","journal-title":"Genome Res"},{"issue":"42","key":"327_CR83","doi-asserted-by":"publisher","first-page":"68638","DOI":"10.18632\/oncotarget.11862","volume":"7","author":"SM Ahn","year":"2016","unstructured":"Ahn SM, Ansari AA, Kim J, Kim D, Chun SM, Kim J, Kim TW, Park I, Yu CS, Jang SJ. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy. Oncotarget. 2016;7(42):68638\u201349.","journal-title":"Oncotarget"},{"issue":"11","key":"327_CR84","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1158\/2159-8290.CD-16-0575","volume":"6","author":"TM Johanns","year":"2016","unstructured":"Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, et al. Immunogenomics of Hypermutated Glioblastoma: a patient with Germline POLE deficiency treated with checkpoint blockade immunotherapy. Cancer Discov. 2016;6(11):1230\u20136.","journal-title":"Cancer Discov"},{"key":"327_CR85","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.critrevonc.2017.03.027","volume":"113","author":"R Bourdais","year":"2017","unstructured":"Bourdais R, Rousseau B, Pujals A, Boussion H, Joly C, Guillemin A, Baumgaertner I, Neuzillet C, Tournigand C. Polymerase proofreading domain mutations: new opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency. Crit Rev Oncol Hematol. 2017;113:242\u20138.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"125","key":"327_CR86","first-page":"113","volume":"23","author":"G Finocchiaro","year":"2017","unstructured":"Finocchiaro G, Langella T, Corbetta C, Pellegatta S. Hypermutations in gliomas: a potential immunotherapy target. Discov Med. 2017;23(125):113\u201320.","journal-title":"Discov Med"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0327-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:14:13Z","timestamp":1751400853000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0327-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":86,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0327-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"13 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by The Ethics committee of A.V. Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation. The study was done in accordance with the principles outlined in the Declaration of Helsinki (1964).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}